Position in OGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$17,149,953
+$9,598,426 QoQ
Shares Held
1,266,614
+0.5% QoQ
Ownership
0.482%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $4,805,415,142 across 12 Drug Manufacturers - General names. OGN ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,255,719 | $1,506,147,163 | |
| 2 | JNJ |
Johnson & Johnson
|
3,383,935 | $859,417,971 | |
| 3 | ABBV |
AbbVie Inc.
|
2,684,208 | $675,454,100 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,751,479 | $610,565,050 | |
| 5 | NVS |
Novartis AG
|
1,565,796 | $245,391,548 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,793,779 | $226,626,038 | |
| 7 | AMGN |
Amgen Inc
|
614,341 | $222,465,162 | |
| 8 | PFE |
Pfizer Inc
|
6,346,636 | $152,826,994 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,149,953 | 1,266,614 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $7,551,527 | 1,260,689 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $8,856,340 | 1,235,194 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $13,318,739 | 1,247,073 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $12,409,856 | 1,282,010 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $19,039,514 | 1,278,678 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $18,632,050 | 1,248,797 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $23,268,048 | 1,216,312 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $56,544,946 | 2,731,640 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $53,642,621 | 2,853,331 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $40,637,692 | 2,818,148 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $33,627,742 | 1,937,082 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $41,080,895 | 1,974,094 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $38,415,778 | 1,633,324 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $40,553,856 | 1,451,982 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $30,532,647 | 1,304,814 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $34,286,928 | 1,015,909 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $33,103,824 | 947,719 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $23,762,326 | 780,372 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $21,051,081 | 641,997 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $17,600,547 | 581,644 | Shares | Defined | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||